1,295 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Versor Investments LP

Versor Investments LP purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,295 shares of the company’s stock, valued at approximately $416,000.

Several other large investors have also recently modified their holdings of HCA. Atlantic Edge Private Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $27,000. Bangor Savings Bank raised its stake in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter valued at about $27,000. Unique Wealth Strategies LLC acquired a new stake in HCA Healthcare in the 2nd quarter worth approximately $28,000. Finally, GPS Wealth Strategies Group LLC raised its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Insiders sold 8,844 shares of company stock worth $3,185,932 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Down 0.4 %

HCA opened at $394.19 on Thursday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $397.73. The company has a market cap of $103.24 billion, a PE ratio of 19.65, a price-to-earnings-growth ratio of 1.52 and a beta of 1.68. The company has a 50-day moving average price of $353.01 and a 200 day moving average price of $334.95.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same period in the previous year, the company posted $4.29 earnings per share. The business’s revenue was up 10.3% on a year-over-year basis. Sell-side analysts expect that HCA Healthcare, Inc. will post 22.5 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Analyst Ratings Changes

A number of brokerages recently issued reports on HCA. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. UBS Group lifted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Royal Bank of Canada raised their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Finally, Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.